Literature DB >> 23521084

Protein C deficiency as the major cause of thrombophilias in childhood.

Shouichi Ohga1, Akira Ishiguro, Yukihiro Takahashi, Midori Shima, Masashi Taki, Masatoki Kaneko, Kotaro Fukushima, Dongchon Kang, Toshiro Hara.   

Abstract

Genetic predisposition of thromboembolism depends on the racial background. Factor V Leiden (G1691A) and factor II mutation (G20210A) are the leading causes of inherited thrombophilias in Caucasians, but are not found in Asian ancestries. Protein S (PS), protein C (PC) and antithrombin (AT) activity are reportedly low in 65% of adult Japanese patients with deep vein thrombosis. Approximately half of the patients with each deficiency carry the heterozygous mutation of PS (PROS1; 20%), PC (PROC; 10%), and AT genes (SERPINC1: 5%). Recently, several studies have revealed an outline of inherited thrombophilias in Japanese children. Congenital thrombophilias in 48 patients less than age 20 years consisted of 45% PC deficiency, 15% PS deficiency and 10% AT deficiency, along with other causes. All PS- and AT-deficient patients had a heterozygous mutation of the respective gene. On the other hand, PC-deficient patients were considered to carry the homozygous or compound heterozygous mutation in 50%, the heterozygous mutation in 25%, and unknown causes in the remaining 25% of patients. Half of unrelated patients with homozygous or compound heterozygous PROC mutations carried PC-nagoya (1362delG), while their parents with its heterozygous mutation were asymptomatic. Most of the PC-deficient patients developed intracranial lesion and/or purpura fulminans within 2 weeks after birth. Non-inherited PC deficiency also conveyed thromboembolic events in early infancy. The molecular epidemiology of thrombosis in Asian children would provide a clue to establish the early intervention and optimal anticoagulant therapy in pediatric PC deficiency.
© 2013 The Authors. Pediatrics International © 2013 Japan Pediatric Society.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23521084     DOI: 10.1111/ped.12102

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  6 in total

1.  Age-specific onset and distribution of the natural anticoagulant deficiency in pediatric thromboembolism.

Authors:  Masako Ichiyama; Shouichi Ohga; Masayuki Ochiai; Koichi Tanaka; Yuka Matsunaga; Takeshi Kusuda; Hirosuke Inoue; Masataka Ishimura; Tomohito Takimoto; Yui Koga; Taeko Hotta; Dongchon Kang; Toshiro Hara
Journal:  Pediatr Res       Date:  2015-09-15       Impact factor: 3.756

2.  Prenatal genetic testing for familial severe congenital protein C deficiency.

Authors:  Shinya Tairaku; Mariko Taniguchi-Ikeda; Yoko Okazaki; Yoriko Noguchi; Yuji Nakamachi; Takeshi Mori; Ikuko Kubokawa; Akira Hayakawa; Akio Shibata; Tomomi Emoto; Hiroki Kurahashi; Tatsushi Toda; Seiji Kawano; Hideto Yamada; Ichiro Morioka; Kazumoto Iijima
Journal:  Hum Genome Var       Date:  2015-06-25

3.  Slow Elevation in Protein C Activity without a PROC Mutation in a Neonate with Intracranial Hemorrhage.

Authors:  Erika Uehara; Hiro Nakao; Yusuke Tsumura; Hisaya Nakadate; Shoichiro Amari; Hideshi Fujinaga; Yoshiyuki Tsutsumi; Dongchon Kang; Shouichi Ohga; Akira Ishiguro
Journal:  AJP Rep       Date:  2018-04-12

4.  Secondary thrombosis prevention practice patterns in pediatrics: Results of an international survey.

Authors:  Hope P Wilson; Rosebella Capio; Inmaculada Aban; Jeffrey Lebensburger; Neil A Goldenberg
Journal:  Res Pract Thromb Haemost       Date:  2022-04-07

5.  Treatment of Growth Hormone Deficiency via Daily Intravascular Injections in a Child with Bleeding Disorder.

Authors:  Emir Tas; Serife E Uzun; Vildan Tas; Juan D Mejia-Otero
Journal:  Case Rep Endocrinol       Date:  2021-06-17

Review 6.  Activated protein C, protease activated receptor 1, and neuroprotection.

Authors:  John H Griffin; Berislav V Zlokovic; Laurent O Mosnier
Journal:  Blood       Date:  2018-06-04       Impact factor: 25.476

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.